⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26075112 | 0.84 | MCL1 (0.43) | — | |
| SCHEMBL8950903 | 0.79 | — | — | |
| SCHEMBL26075110 | 0.79 | SAT1 (0.39) | — | |
| SCHEMBL15425740 | 0.78 | — | — | |
| SCHEMBL8950864 | 0.77 | — | — | |
| SCHEMBL12629263 | 0.77 | SAT1 (0.42) | — | |
| SCHEMBL22661435 | 0.77 | MCL1 (0.44) | — | |
| SCHEMBL1198895 | 0.75 | EPHX1 (0.58) | — | |
| SCHEMBL15358860 | 0.74 | — | — | |
| SCHEMBL1750112 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3082867-B1 | ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS | INTERVET INT BV (NL) | 2024-01-17 | — | — | EP | claimed |
| EP-4076447-B1 | PARASITE CONTROL IN RUMINANTS | INTERVET INT BV (NL) | 2024-01-17 | — | — | EP | claimed |
| EP-3707128-B1 | INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION | INTERVET INT BV (NL) | 2023-12-20 | — | — | EP | claimed |
| EP-4153133-B1 | INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | INTERVET INT BV (NL) | 2023-11-08 | — | — | EP | claimed |
| EP-3878281-B1 | USE OF ISOXAZOLINE COMPOUNDS IN POULTRY | INTERVET INT BV (NL) | 2023-05-24 | — | — | EP | claimed |
| EP-2833867-B2 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | INTERVET INT BV (NL) | 2023-05-10 | — | — | EP | claimed |
| EP-2658542-B1 | TOPICAL LOCALIZED ISOXAZOLINE FORMULATION | INTERVET INT BV (NL) | 2022-01-26 | — | — | EP | claimed |
| EP-3082806-B1 | USE OF ISOXAZOLINE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF ARTHROPOD INFESTATIONS IN POULTRY | INTERVET INT BV (NL) | 2021-05-12 | — | — | EP | claimed |
| EP-2833866-B1 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | INTERVET INT BV (NL) | 2018-11-21 | — | — | EP | claimed |
| EP-2833867-B1 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | INTERVET INT BV (NL) | 2017-05-17 | — | — | EP | claimed |
| US-20140018372-A1 | CRYSTALLINE FORM OF A INDOLINONE DERIVATIVE AND ITS USE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-16 | — | — | US | claimed |
| WO-2014009318-A1 | 3-{3-[1 -(4-DIMETHYLAMINOMETHYL-PHENYLAMINO)-1 -PHENYL-METH-(Z)-YLIDENE]-2-OXO-2,3-DIHYDRO-1 H-INDOL-6-YLL-PROPYNOIC ACID ETHYLAMIDE AND ITS USE IN THE TREATMENT OF CANCER | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-16 | — | — | WO | claimed |
| US-20090182020-A1 | SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS | GRUNENTHAL GMBH (DE) | 2009-07-16 | — | — | US | claimed |
| EP-1968935-A1 | SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS | Grünenthal GmbH (DE) | 2008-09-17 | — | — | EP | claimed |
| WO-2007079958-A1 | SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS | Grünenthal GmbH (DE) | 2007-07-19 | — | — | WO | claimed |
| EP-0166171-B1 | SUBSTITUTED PYRAZOLIN-5-ONE | BAYER AG (DE) | 1988-12-07 | — | — | EP | claimed |
| US-11976075-B2 | Inhibitors of the MYST family of lysine acetyl transferases | Isosterix, Inc. | 2024-05-07 | — | — | US | disclosed |
| EP-4346826-A1 | COMBINATION THERAPIES | Mirati Therapeutics, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| US-3957814-A | DIURETICS, SALURETICS, HYPOTENSIVE AGENTS, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
| US-3952008-A | DIURETIC, SALURETIC, HYPOTENSIVE, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | disclosed |